Zymeworks (ZYME) Cash & Equivalents: 2021-2022
Historic Cash & Equivalents for Zymeworks (ZYME) over the last 2 years, with Dec 2022 value amounting to $400.9 million.
- Zymeworks' Cash & Equivalents fell 1.82% to $94.3 million in Q3 2023 from the same period last year, while for Sep 2023 it was $94.3 million, marking a year-over-year decrease of 1.82%. This contributed to the annual value of $400.9 million for FY2022, which is 98.60% up from last year.
- As of FY2022, Zymeworks' Cash & Equivalents stood at $400.9 million, which was up 98.60% from $201.9 million recorded in FY2021.
- Over the past 5 years, Zymeworks' Cash & Equivalents peaked at $400.9 million during FY2022, and registered a low of $201.9 million during FY2021.
- Its 2-year average for Cash & Equivalents is $301.4 million, with a median of $301.4 million in 2021.
- Data for Zymeworks' Cash & Equivalents shows a peak YoY surged of 98.60% (in 2022) over the last 5 years.
- Over the past 2 years, Zymeworks' Cash & Equivalents (Yearly) stood at $201.9 million in 2021, then soared by 98.60% to $400.9 million in 2022.